Clinical Trial Update: Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intensive ambulance-delivered blood pressure reduction for hyper-acute stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disorders
• Stroke

Drugs mentioned

• Ambulance-delivered antihypertensive therapy

Snippet

Sponsor: The George Institute for Global Health, China | Conditions: Stroke, Acute, Cerebrovascular Disorders | Phase 3 | Status: COMPLETED